HK1196371A1 - 被取代的咪唑並吡啶基-氨基吡啶化合物 - Google Patents
被取代的咪唑並吡啶基-氨基吡啶化合物Info
- Publication number
- HK1196371A1 HK1196371A1 HK14109924.6A HK14109924A HK1196371A1 HK 1196371 A1 HK1196371 A1 HK 1196371A1 HK 14109924 A HK14109924 A HK 14109924A HK 1196371 A1 HK1196371 A1 HK 1196371A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- substituted imidazopyridinyl
- aminopyridine compounds
- aminopyridine
- compounds
- imidazopyridinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161500889P | 2011-06-24 | 2011-06-24 | |
| PCT/US2012/043501 WO2012177844A2 (en) | 2011-06-24 | 2012-06-21 | Substituted imidazopyridinyl-aminopyridine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1196371A1 true HK1196371A1 (zh) | 2014-12-12 |
Family
ID=47362419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK14109924.6A HK1196371A1 (zh) | 2011-06-24 | 2014-10-06 | 被取代的咪唑並吡啶基-氨基吡啶化合物 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8609688B2 (zh) |
| EP (1) | EP2723741B8 (zh) |
| JP (1) | JP6046710B2 (zh) |
| KR (2) | KR101974673B1 (zh) |
| CN (1) | CN103748093B (zh) |
| AU (2) | AU2012272937B2 (zh) |
| BR (1) | BR112013033182A2 (zh) |
| CA (1) | CA2837727C (zh) |
| DK (1) | DK2723741T3 (zh) |
| ES (1) | ES2579855T3 (zh) |
| HK (1) | HK1196371A1 (zh) |
| IL (3) | IL229719A0 (zh) |
| MX (1) | MX339862B (zh) |
| PH (1) | PH12013502565B1 (zh) |
| TW (1) | TWI561522B (zh) |
| WO (1) | WO2012177844A2 (zh) |
| ZA (1) | ZA201308929B (zh) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE534415T1 (de) | 2005-12-13 | 2011-12-15 | Harvard College | Gerüste zur zelltransplantation |
| WO2009002401A2 (en) | 2007-06-21 | 2008-12-31 | President And Fellows Of Harvard College | Scaffolds for cell collection or elimination |
| AU2009215188B2 (en) | 2008-02-13 | 2014-09-18 | Dana-Farber Cancer Institute, Inc. | Continuous cell programming devices |
| US9370558B2 (en) | 2008-02-13 | 2016-06-21 | President And Fellows Of Harvard College | Controlled delivery of TLR agonists in structural polymeric devices |
| WO2009146456A1 (en) * | 2008-05-30 | 2009-12-03 | President And Fellows Of Harvard College | Controlled release of growth factors and signaling molecules for promoting angiogenesis |
| WO2010120749A2 (en) | 2009-04-13 | 2010-10-21 | President And Fellow Of Harvard College | Harnessing cell dynamics to engineer materials |
| JP5926180B2 (ja) | 2009-07-31 | 2016-05-25 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 寛容原性療法のための細胞のプログラミングの方法 |
| WO2011103289A2 (en) * | 2010-02-17 | 2011-08-25 | Jasco Pharmaceuticals, LLC | Imidazole-2, 4-dione inhibitors of casein kinase 1 |
| EP2585053A4 (en) | 2010-06-25 | 2014-02-26 | Harvard College | COMMON RELEASE OF STIMULATING AND HEMMING FACTORS FOR THE PRODUCTION OF TEMPORARY STABILIZED AND SPATULARLY LIMITED ZONES |
| DK2624873T3 (da) | 2010-10-06 | 2020-03-02 | Harvard College | Injicerbare, pore-dannende hydrogeler til materiale-baserede celleterapier |
| WO2012064697A2 (en) | 2010-11-08 | 2012-05-18 | President And Fellows Of Harvard College | Materials presenting notch signaling molecules to control cell behavior |
| WO2012148684A1 (en) | 2011-04-27 | 2012-11-01 | President And Fellows Of Harvard College | Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation |
| WO2012149358A1 (en) | 2011-04-28 | 2012-11-01 | President And Fellows Of Harvard College | Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration |
| US9675561B2 (en) | 2011-04-28 | 2017-06-13 | President And Fellows Of Harvard College | Injectable cryogel vaccine devices and methods of use thereof |
| US9486512B2 (en) | 2011-06-03 | 2016-11-08 | President And Fellows Of Harvard College | In situ antigen-generating cancer vaccine |
| KR101974673B1 (ko) * | 2011-06-24 | 2019-05-02 | 아르퀼 인코포레이티드 | 치환된 이미다조피리디닐-아미노피리딘 화합물 |
| DK2838515T3 (da) | 2012-04-16 | 2020-02-24 | Harvard College | Mesoporøse siliciumdioxidsammensætninger til modulering af immunresponser |
| CN105764501A (zh) | 2013-07-26 | 2016-07-13 | 现代化制药公司 | 改善比生群治疗效益的组合物 |
| JP6578298B2 (ja) | 2014-03-24 | 2019-09-18 | アークル インコーポレイテッド | ３−（３−（４−（１−アミノシクロブチル）フェニル）−５−フェニル−３ｈ−イミダゾ［４，５−ｂ］ピリジン−２−イル）ピリジン−２−アミンを調製する方法 |
| SG11201608303QA (en) | 2014-04-04 | 2016-11-29 | Del Mar Pharmaceuticals | Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer |
| EP3653627A1 (en) * | 2014-04-22 | 2020-05-20 | ArQule, Inc. | Polymorphs of a substituted imidazopyridinyl-aminopyridine compound |
| JP7348708B2 (ja) | 2014-04-30 | 2023-09-21 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 組み合わせワクチン装置および癌細胞を殺滅する方法 |
| CA2958770A1 (en) | 2014-09-05 | 2016-03-10 | Arqule, Inc. | Compositions and methods for treating proliferation disorders |
| US11786457B2 (en) | 2015-01-30 | 2023-10-17 | President And Fellows Of Harvard College | Peritumoral and intratumoral materials for cancer therapy |
| US11150242B2 (en) | 2015-04-10 | 2021-10-19 | President And Fellows Of Harvard College | Immune cell trapping devices and methods for making and using the same |
| CN105315161B (zh) * | 2015-06-05 | 2017-08-04 | 厦门医学院 | 一类PKB/Akt抑制剂的关键中间体的制备方法 |
| CN115487351A (zh) | 2016-02-06 | 2022-12-20 | 哈佛学院校长同事会 | 重塑造血巢以重建免疫 |
| WO2018013430A2 (en) | 2016-07-12 | 2018-01-18 | Arisan Therapeutics Inc. | Heterocyclic compounds for the treatment of arenavirus infection |
| JP2019522486A (ja) | 2016-07-13 | 2019-08-15 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 抗原提示細胞模倣足場およびそれを作製および使用するための方法 |
| JP2022506508A (ja) | 2018-11-05 | 2022-01-17 | アイオバンス バイオセラピューティクス，インコーポレイテッド | Ａｋｔ経路阻害剤を利用したｔｉｌの拡大培養 |
| TW202214631A (zh) * | 2020-09-30 | 2022-04-16 | 中國商正大天晴藥業集團股份有限公司 | 作為Akt激酶抑制劑的化合物 |
| EP4347041A1 (en) | 2021-05-28 | 2024-04-10 | Taiho Pharmaceutical Co., Ltd. | Small molecule inhibitors of kras mutated proteins |
| US20240079084A1 (en) * | 2022-08-19 | 2024-03-07 | Atomic Ai, Inc. | Methods, systems, and media method applying machine learning to chemical mapping data for rna tertiary structure prediction |
| WO2024178390A1 (en) * | 2023-02-24 | 2024-08-29 | Terremoto Biosciences, Inc. | Covalent modifiers of akt1 and uses thereof |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| DE3722992A1 (de) | 1987-07-11 | 1989-01-19 | Thomae Gmbh Dr K | Neue imidazo-pyridine und purine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| CA2002859C (en) | 1988-11-29 | 1998-12-29 | Jean P. F. Van Wauwe | Method of treating epithelial disorders |
| DE4129603A1 (de) | 1991-09-06 | 1993-03-11 | Thomae Gmbh Dr K | Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| AU4436196A (en) | 1994-12-28 | 1996-07-19 | Janssen Pharmaceutica N.V. | Benzimidazoles as inhibitors of calcitriol metabolism |
| AU3538899A (en) | 1998-04-30 | 1999-11-23 | Nippon Chemiphar Co. Ltd. | Condensed imidazole derivative and therapeutic agent for liver disease |
| JP2000344780A (ja) | 1998-09-24 | 2000-12-12 | Fuji Photo Film Co Ltd | 新規ベンゾピラン化合物、発光素子材料及びそれを使用した発光素子 |
| US6403588B1 (en) * | 2000-04-27 | 2002-06-11 | Yamanouchi Pharmaceutical Co., Ltd. | Imidazopyridine derivatives |
| GB0206860D0 (en) | 2002-03-22 | 2002-05-01 | Glaxo Group Ltd | Compounds |
| GB0206861D0 (en) | 2002-03-22 | 2002-05-01 | Glaxo Group Ltd | Medicaments |
| SI1499316T1 (sl) | 2002-04-18 | 2008-08-31 | Schering Corp | (1-4-piperidinil)benzimidazolni derivati, koristni kot antagonisti histamina H3 |
| AR045134A1 (es) | 2003-07-29 | 2005-10-19 | Smithkline Beecham Plc | Compuesto de 1h - imidazo [4,5-c] piridin-ilo, composicion farmaceutica que lo comprende, proceso para prepararla, su uso para preparar dicha composicion farmaceutica, combinacion farmaceutica, uso de la combinacion farmaceutica para la preparacion de un medicamento, procedimientos para preparar dic |
| US7442709B2 (en) * | 2003-08-21 | 2008-10-28 | Osi Pharmaceuticals, Inc. | N3-substituted imidazopyridine c-Kit inhibitors |
| WO2005021544A2 (en) * | 2003-08-21 | 2005-03-10 | Osi Pharmaceuticals, Inc. | N3-substituted imidazopyridine-derivatives as c-kit inhibitors |
| CA2669736C (en) | 2005-11-03 | 2017-02-21 | Chembridge Research Laboratories, Inc. | Heterocyclic compounds as tyrosine kinase modulators |
| BRPI0620386A2 (pt) | 2005-12-21 | 2011-12-20 | Schering Corp | composição compreendendo a combinação de um antagonista de h3/agonista inverso e um supressor de apetite e uso da referida composição |
| DE602007004092D1 (de) | 2006-03-22 | 2010-02-11 | Vertex Pharma | C-met-proteinkinasehemmer zur behandlung proliferativer erkrankungen |
| CN100398540C (zh) | 2006-04-03 | 2008-07-02 | 大连理工大学 | 芳杂环基咪唑并萘酰亚胺类化合物及其应用 |
| MY157033A (en) | 2006-07-11 | 2016-04-15 | Dae Woong Pharma | Novel biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same |
| AR064010A1 (es) * | 2006-12-06 | 2009-03-04 | Merck & Co Inc | Inhibidores de la actividad de la akt |
| CA2679809A1 (en) | 2007-03-02 | 2008-09-12 | Schering Corporation | Benzimidazole derivatives and methods of use thereof |
| WO2009000413A1 (en) | 2007-06-26 | 2008-12-31 | Sanofi-Aventis | A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles |
| TW200932872A (en) | 2007-10-17 | 2009-08-01 | Cheil Ind Inc | Novel compound for organic photoelectric device and organic photoelectric device including the same |
| KR20090007347U (ko) | 2008-01-16 | 2009-07-21 | 춘-치 왕 | 가속 페달 포지션 센서를 구비한 자동차용 연료 공급 기구 |
| US8501770B2 (en) * | 2009-12-30 | 2013-08-06 | Arqule, Inc. | Substituted imidazopyridinyl-aminopyridine compounds |
| KR101974673B1 (ko) * | 2011-06-24 | 2019-05-02 | 아르퀼 인코포레이티드 | 치환된 이미다조피리디닐-아미노피리딘 화합물 |
| WO2012177852A1 (en) | 2011-06-24 | 2012-12-27 | Arqule, Inc | Substituted imidazopyridinyl compounds |
-
2012
- 2012-06-21 KR KR1020137034886A patent/KR101974673B1/ko active IP Right Grant
- 2012-06-21 ES ES12802947.7T patent/ES2579855T3/es active Active
- 2012-06-21 CA CA2837727A patent/CA2837727C/en active Active
- 2012-06-21 EP EP12802947.7A patent/EP2723741B8/en active Active
- 2012-06-21 KR KR1020197003119A patent/KR20190015600A/ko not_active Application Discontinuation
- 2012-06-21 AU AU2012272937A patent/AU2012272937B2/en active Active
- 2012-06-21 US US13/529,459 patent/US8609688B2/en active Active
- 2012-06-21 DK DK12802947.7T patent/DK2723741T3/en active
- 2012-06-21 MX MX2013015006A patent/MX339862B/es active IP Right Grant
- 2012-06-21 WO PCT/US2012/043501 patent/WO2012177844A2/en active Application Filing
- 2012-06-21 BR BR112013033182A patent/BR112013033182A2/pt not_active Application Discontinuation
- 2012-06-21 CN CN201280030830.8A patent/CN103748093B/zh active Active
- 2012-06-21 JP JP2014517149A patent/JP6046710B2/ja active Active
- 2012-06-22 TW TW101122473A patent/TWI561522B/zh active
-
2013
- 2013-11-08 US US14/075,505 patent/US8962619B2/en active Active
- 2013-11-27 ZA ZA2013/08929A patent/ZA201308929B/en unknown
- 2013-11-28 IL IL229719A patent/IL229719A0/en active IP Right Grant
- 2013-12-10 PH PH12013502565A patent/PH12013502565B1/en unknown
-
2014
- 2014-10-06 HK HK14109924.6A patent/HK1196371A1/zh unknown
-
2016
- 2016-12-05 AU AU2016269408A patent/AU2016269408B2/en active Active
-
2019
- 2019-04-08 IL IL265897A patent/IL265897B/en unknown
-
2021
- 2021-09-05 IL IL286152A patent/IL286152A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286152A (en) | Modified imidazopyridinyl-aminopyridine compounds | |
| IL229513A0 (en) | imidazopyridine compounds | |
| HK1187259A1 (zh) | 取代的喹啉化合物 | |
| IL233154A0 (en) | compounds | |
| HK1203196A1 (zh) | 取代的苄基吡唑 | |
| EP2738170A4 (en) | HETEROCYCLIC COMPOUND | |
| GB201109763D0 (en) | Compounds | |
| GB201106395D0 (en) | Compounds | |
| ZA201306857B (en) | Mesogen-containing compounds | |
| EP2709609A4 (en) | HETEROCYCLIC COMPOUNDS | |
| GB201122139D0 (en) | Compounds | |
| GB201107197D0 (en) | Compounds | |
| IL229064A0 (en) | A new derivative of 3-hydroxyisothiazole 1-oxide | |
| EP2717694A4 (en) | NEW COMPOUNDS | |
| GB201110938D0 (en) | Compounds | |
| HK1191326A1 (zh) | 氮雜螺環癸酮化合物 | |
| GB201105659D0 (en) | Compounds | |
| HK1215569A1 (zh) | 吡啶酮化合物 | |
| GB201118613D0 (en) | Compounds | |
| HUP1100731A2 (en) | Complex forming compounds | |
| GB201120805D0 (en) | Compounds | |
| GB201119703D0 (en) | Compounds | |
| GB201119745D0 (en) | Compounds | |
| GB201115827D0 (en) | Compounds | |
| GB201115829D0 (en) | Compounds |